Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook

Vlad Iova, Gilda Mihaela Iova, Mihail Silviu Tudosie, Ioana Scrobota, Catalin Gabriel Smarandache

Open source

DOI
10.1002/ctm2.70702
Published
2026-05
Container
Clinical and Translational Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70702,
  title = {Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook},
  author = {Vlad Iova and Gilda Mihaela Iova and Mihail Silviu Tudosie and Ioana Scrobota and Catalin Gabriel Smarandache},
  year = {2026},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.70702},
  url = {https://doi.org/10.1002/ctm2.70702}
}

RIS

TY  - JOUR
TI  - Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook
AU  - Vlad Iova
AU  - Gilda Mihaela Iova
AU  - Mihail Silviu Tudosie
AU  - Ioana Scrobota
AU  - Catalin Gabriel Smarandache
PY  - 2026
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.70702
UR  - https://doi.org/10.1002/ctm2.70702
ER  - 

APA

Iova, V., Iova, G. M., Tudosie, M. S., Scrobota, I., & Smarandache, C. G. (2026). Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70702

Source records